Clinical Trial Update: REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

View source ↗

Summary

The REVEAL Registry study evaluating early and long-term management of pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension | Status: COMPLETED